Is Curcumin a Possibility to Treat Inflammatory Bowel Diseases?

논문상세정보

' Is Curcumin a Possibility to Treat Inflammatory Bowel Diseases?' 의 참고문헌

  • Z-ligustilide ameliorated ultraviolet B-induced oxidative stress and inflammatory cytokine production in human keratinocytes through upregulation of Nrf2/HO-1and suppression of NF-jBpathway
    Wu Z [2015]
  • Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies
    Ng SC [2017]
  • Understanding inflammatory bowel disease via immunogenetics
    de Lange KM [2015]
  • Turmeric (curcumin) remedies gastroprotective action
    Yadav SK [2013]
  • Treatment of inflammatory bowel disease: A review of medical therapy
    Kozuch PL [2008]
  • Tolerability of curcumin in pediatric inflammatory bowel disease: A forced dose titration study
    Suskind DL [2013]
  • Therapeutic roles of curcumin:lessons learned from clinical trials
    Gupta SC [2013]
  • Therapeutic potential of curcumin in gastrointestinal diseases
  • Therapeutic potential of curcumin in digestive diseases
    Dulbecco P [2013]
  • The spice for joint inflammation: Anti-inflammatory role of curcumin in treating osteoarthritis
    Chin KY [2016]
  • The innate immune system and inflammatory bowel disease
    Davies JM [2015]
  • The immunological basis of inflammatory bowel disease
    Silva FA [2016]
  • The burden of inflammatory bowel disease in Europe
    Burisch J [2013]
  • Th9 cells in inflammatory bowel diseases
    Weigmann B [2017]
  • Th9 cells and IL-9 in autoimmune disorders: Pathogenesis and therapeutic potentials
    DengY [2017]
  • Role of gut microbiota in a zebrafish model with chemically induced enterocolitis involving toll-like receptor signaling pathways
    He Q [2014]
  • Role of Th17 cells in the pathogenesis of human IBD
    Galvez J [2014]
  • Reflections about osteoarthritis and Curcuma longa
    Akuri MC [2017]
  • Redox regulation ofMMP-3/TIMP-1ratioinintestinal myofibroblasts: EffectofNacetylcysteineandcurcumin
    Fontani F [2014]
  • Radio protective effects of the Ayurvedic medicinal plant Ocimum sanctum Linn. (Holy Basil):a memoir
    Baliga MS [2016]
  • Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases
    Aggarwal BB [2009]
  • Pharmacological activities of turmeric (Curcuma longa linn): A review
    Krup V [2013]
  • NOD2 gene mutation in Moroccan patients with Crohn’s disease: Prevalence, genotypic study and correlation of NOD2 gene mutation with the phenotype of Crohn’s disease [In French]
  • Low dose oral curcumin is not effective in induction of remission in mild to moderate ulcerative colitis: Results from a randomized double blind placebo controlled trial
    Kedia S [2017]
  • Inflammatory bowel diseases: Review of known environmental protective and risk factors involved
  • Inflammatory bowel disease: pathogenesis
    Zhang YZ [2014]
  • Inflammatory bowel disease: Can omega-3 fatty acids really help?
    Barbalho SM [2016]
  • Inflammatory bowel disease, colorectal cancer and type 2 diabetes mellitus: The links
    Jurjus A [2016]
  • Induction with NCB-02 (curcumin) enema for mild-to-moderate distal ulcerative colitis—a randomized, placebo-controlled, pilot study
    Singla V [2014]
  • In vitro antidiabetic and inhibitory potential of turmeric (Curcuma longa L) rhizome against cellular and LDL oxidation and angiotensin converting enzyme
    Lekshmi PC [2014]
  • Immunoregulation of inflammatory and inhibitory cytokines by vitamin D3 in patients with inflammatory bowel diseases (IBD)
  • Immunopathophysiology of inflammatory bowel disease: How genetics link barrier dysfunction and innate immunity to inflammation
    Mehta M [2017]
  • Immunopathology of inflammatory bowel disease
    Wallace KL [2014]
  • Immunopathogenesis of inflammatory bowel disease: Current concepts
    Bamias G [2007]
  • Immune aspects of the pathogenesis of inflammatory bowel disease
  • From common to rare Zingiberaceae plants—A metabolomics study using GCMS
    Barbosa GB [2017]
  • Extracts from Hericium erinaceus relieve inflammatory bowel disease by regulating immunity and gut microbiota
    Diling C [2017]
  • Expression of peroxisome proliferator-activated receptor-c in macrophage suppresses experimentally-induced colitis
    Shah YM [2007]
  • Essential oil content of the rhizome of Curcuma purpurascens Bl. (Temu Tis)and its antiproliferative effect on selected human carcinoma cell lines
    Hong S-L [2014]
  • Epidemiology and natural history of inflammatory bowel diseases
    Cosnes J [2011]
  • Effect of polyherbal formulation on experimental models of inflammatory bowel diseases
    Jagtap A [2004]
  • Effect of differently structured and processed feedstuffs on diverse parameters of ethology and digestibility of growing rabbits and their influence on morphological structures in small intestine
    Lang C [2016]
  • Diversity of intestinal macrophages in inflammatory bowel diseases
    Kuhl AA [2015]
  • Dietary Therapies in pediatric inflammatory bowel disease: An evolving inflammatory bowel disease paradigm
    Lane ER [2017]
  • Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers
    Aggarwal BB [2013]
  • Curcumin: From ancient medicine to current clinical trials
    Hatcher H [2008]
  • Curcumin, an active component of turmeric in the prevention and treatment of ulcerative colitis: preclinical and clinical observations
    Baliga MS [2012]
  • Curcumin, a Curcuma longa constituent, acts on MAPK p38pathway modulating COX-2 and iNOS expression in chronic experimental colitis
  • Curcumin suppresses p38 mitogen-activated protein kinase activation, reduces IL-1beta and matrix metalloproteinase-3 and enhances IL-10 in the mucosa of children and adults with inflammatory bowel disease
    Epstein J [2010]
  • Curcumin protects neuron against cerebral ischemia-induced inflammation through improving PPAR-gamma function
    Liu Z-J [2013]
  • Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial
    Hanai H [2006]
  • Curcumin loaded microsponges for colon targeting in inflammatory bowel disease: fabrication, optimization, and in vitro and pharmacodynamic evaluation
    Sareen R [2014]
  • Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages
    Abe Y [1999]
  • Curcumin in inflammatory diseases
    Shehzad A [2013]
  • Curcumin in combination with mesalamine induces remission in patients with mild-tomoderate Ulcerative colitis in a randomized controlled trial
    Lang A [2015]
  • Curcumin has bright prospects for the treatment of inflammatory bowel disease
    Hanai H [2009]
  • Curcumin half analog modulates interleukin-6 and tumor necrosis factor-alpha in inflammatory bowel disease
  • Curcumin for inflammatory bowel disease: a review of human studies
    Taylor RA [2011]
  • Curcumin attenuates oxidative stress and activation of redox-sensitive kinases in high fructose- and high-fat-fed male Wistar rats
  • Curcumin attenuates hypoxicischemic brain injury in neonatal rats through induction of nuclear factor erythroid-2-related factor 2 and heme oxygenase-1
    Cui X [2017]
  • Curcumin attenuates cardiomyocyte hypertrophy induced by high glucose and insulin via the PPARg/Akt/NO signaling pathway
    Chen R [2015]
  • Curcumin attenuates acute inflammatory injury by inhibiting the TLR4/MyD88/NF-jB signaling pathway in experimental traumatic brain injury
    Zhu HT [2014]
  • Curcumin and inflammatory bowel disease: potential and limits of innovative treatments
  • Curcumin acts via transient receptor potential vanilloid-1 receptors to inhibit gut nociception and reverses visceral hyperalgesia
    Zhi L [2013]
  • Comparison of remicade to curcumin for the treatment of Crohn’s disease: A systematic review
    Schneider A [2017]
  • Commensal-specific CD4(+) cells from patients with Crohn’s disease have a T-helper 17 inflammatory profile
  • Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: lessons learned from animal models and human genetics
  • Association of inflammatory cytokine gene polymorphisms with inflammatory bowel disease in a Moroccan cohort
    Senhaji N [2016]
  • Antioxidant supplements and gastrointestinal diseases: A critical appraisal
    Khan I [2017]
  • Anti-oncogenic perspectives of spices/herbs: A comprehensive review
    Butt MS [2013]
  • Anti-TNF therapy is able to stabilize bowel damage progression in patients with Crohn’s disease. A study performed using the Le´mann index
    Bodini G [2017]
  • An update on Curcuma as a functional food in the control of cancer and inflammation
    Schaffer M [2015]
  • Aminoguanidine and curcumin attenuated tumor necrosis factor (TNF)-a-induced oxidative stress, colitis and hepatotoxicity in mice
    Mouzaoui S [2012]